Renin–angiotensin–aldosterone system inhibitors (RAASi) were associated with reduced risk of mortality (Pooled HR 0.58, 95% CI 0.43 to 0.80, p=0.006), The differences in changes of haemodynamic or echocardiographic parameters from baseline with and without AHT did not reach statistical significance.
← all excerpts
Antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis.
1
—
—